Dyadic International, Inc. ( DYAI) - Key Metrics
DYAI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.03 | -$0.06 | -$0.05 | -$0.05 |
| 2026Q1 | $0.03 | -$0.05 | -$0.05 | -$0.05 |
| 2025Q4 | $0.01 | -$0.05 | -$0.05 | -$0.05 |
| 2025Q3 | $0.03 | -$0.06 | -$0.05 | -$0.05 |
| 2025Q2 | $0.02 | -$0.06 | $0 | $0 |
DYAI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.73 |
| 2026Q1 | 0% | -4.10 |
| 2025Q4 | 0% | -5.43 |
| 2025Q3 | 0% | -4.92 |
| 2025Q2 | 0% | -4.15 |
DYAI
Price: $0.42
52 week price:
Earnings Per Share: -0.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 58579
Market Capitalization: 16.5 million